Stay updated with breaking news from Mac Mahon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials
Results from two parallel trials show Cosentyx (secukinumab) demonstrated superior efficacy vs placebo with statistically significant improvement in hidradenitis suppurativa (HS) signs and symptoms1Safety
In his role as MC on May 4th, Dominic West will be introducing an eclectic line-up of speakers
Years ago a syndicated columnist described Saint Peter’s campus as ‘what you see is what you get.’ The words of Star Ledger (NJ) columnist emeritus Jerry Izenberg, still resonate today. Before...